REQUEST A DEMO
Total
USD $0.00
Search more companies

Ips Bio-Salud Sociedad Anonima (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Pharmacies and Drug Stores | Hotels (except Casino Hotels) and Motels | Special Food Services
Full name: Ips Bio-Salud Sociedad Anonima Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Ips Bio-Salud Sociedad Anonima is an enterprise based in Colombia. Its main office is in Duitama. It operates in the Ambulatory Health Care Services industry. The company was established on March 01, 2004. The latest financial highlights indicate a net sales revenue increase of 13.34% in 2023. Its’ total assets recorded a growth of 0.66%. The net profit margin of Ips Bio-Salud Sociedad Anonima decreased by 9.87% in 2023.

Headquarters
Km 5 Via Duitama Paipa
Duitama; Boyaca;

Contact Details: Purchase the Ips Bio-Salud Sociedad Anonima report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ips Bio-Salud Sociedad Anonima report to view the information.
Incorporation Date:
March 01, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Ips Bio-Salud Sociedad Anonima report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
13.34%
Total operating revenue
13.34%
Operating profit (EBIT)
-4.73%
EBITDA
-5%
Net Profit (Loss) for the Period
-1595.57%
Total assets
0.66%
Total equity
-5.87%
Operating Profit Margin (ROS)
2.7%
Net Profit Margin
-9.87%
Return on Equity (ROE)
-2.76%
Debt to Equity Ratio
1.46%
Quick Ratio
0.01%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?